These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7145937)

  • 21. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
    Brace LD; Venton DL; Le Breton GC
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H1-7. PubMed ID: 3925795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidiuretic and thermogenic effects of intracerebroventricular prostaglandin H2 in ethanol-anaesthetized rats.
    Fujimoto S; Tsushima H; Mori M
    Experientia; 1980 Feb; 36(2):209-11. PubMed ID: 7371762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
    Brace LD; Venton DL; Le Breton GC
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H8-13. PubMed ID: 2409821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic studies on Prostanoids. XX. Synthesis of stable (+/-)-prostaglandin H1 analogs.
    Sakai K; Inoue K; Amemiya S; Morita A; Kojima K
    Chem Pharm Bull (Tokyo); 1980 Jun; 28(6):1814-9. PubMed ID: 7408058
    [No Abstract]   [Full Text] [Related]  

  • 25. Prostaglandins and the ductus arteriosus.
    Friedman WF; Printz MP; Skidgel RA; Benson LN; Zednikova M
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():277-302. PubMed ID: 6216785
    [No Abstract]   [Full Text] [Related]  

  • 26. Arachidonic acid responses in the lung.
    Kadowitz PJ; McNamara DB; She HS; Spannhake EW; Hyman AL
    Bull Eur Physiopathol Respir; 1981; 17(4):659-73. PubMed ID: 6799028
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations.
    Coleman RA; Humphrey PP; Kennedy I; Levy GP; Lumley P
    Br J Pharmacol; 1981 Jul; 73(3):773-8. PubMed ID: 7248665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandins and uterine contractility.
    Wiqvist N; Lindblom B; Wikland M; Wilhelmsson L
    Acta Obstet Gynecol Scand Suppl; 1983; 113():23-9. PubMed ID: 6574679
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of histamine-sensitive adenylate cyclase from guinea pig fundic gastric mucosa by arachidonic acid and by an analog of prostaglandin endoperoxide PGH2.
    Dozois RR; Madson TH; Dousa TP
    Dig Dis Sci; 1980 Apr; 25(4):273-8. PubMed ID: 7389526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accelerative autoactivation of prostaglandin biosynthesis by PGG2.
    Hemler ME; Graff G; Lands WE
    Biochem Biophys Res Commun; 1978 Dec; 85(4):1325-31. PubMed ID: 105736
    [No Abstract]   [Full Text] [Related]  

  • 31. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
    Hornberger WB; Patscheke H
    Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the prostaglandin H2/thromboxane A2 antagonist BM 13.177 on human platelets.
    Patscheke H; Stegmeier K
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():371-3. PubMed ID: 3159225
    [No Abstract]   [Full Text] [Related]  

  • 33. Thromboxane A2/prostaglandin H2 directly stimulates platelet shape change independent of secreted ADP.
    Parise LV; Venton DL; Le Breton GC
    J Pharmacol Exp Ther; 1982 Jul; 222(1):276-81. PubMed ID: 7086705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PGD3 is the mediator of the antiaggregatory effects of the trienoic endoperoxide PGH3.
    Whitaker MO; Needleman P; Wyche A; Fitzpatrick FA; Sprecher H
    Adv Prostaglandin Thromboxane Res; 1980; 6():301-3. PubMed ID: 6966885
    [No Abstract]   [Full Text] [Related]  

  • 35. Bronchial and cardiovascular actions of prostaglandin endoperoxides and an endoperoxide analogue.
    Hedqvist P; Strandberg K; Hamberg M
    Acta Physiol Scand; 1978 Jul; 103(3):299-307. PubMed ID: 726925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet thromboxane A2/endoperoxide (TXA2/PGH2) receptors in type I diabetes mellitus.
    Jaschonek K; Faul C; Weisenberger H; Krönert K; Schröder H; Renn W
    Thromb Haemost; 1989 Jun; 61(3):535-6. PubMed ID: 2529665
    [No Abstract]   [Full Text] [Related]  

  • 37. From studies of biochemical mechanism to novel biological mediators: prostaglandin endoperoxides, thromboxanes, and leukotrienes. Nobel Lecture, 8 December 1982.
    Samuelsson B
    Biosci Rep; 1983 Sep; 3(9):791-813. PubMed ID: 6315101
    [No Abstract]   [Full Text] [Related]  

  • 38. Biosynthesis of prostaglandin F2 alpha from prostaglandins H2 and D2 by an apparently homogeneous enzyme.
    Watanabe K; Yoshida R; Shimizu T; Hayaishi O
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():151-3. PubMed ID: 2936081
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP.
    Morinelli TA; Naka M; Masuda A; Oatis JE; Okwu AK; Mais DE; Saussy DL; Halushka PV
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():331-7. PubMed ID: 1825565
    [No Abstract]   [Full Text] [Related]  

  • 40. Renal vascular responsiveness to arachidonic acid in experimental diabetes.
    Quilley J; McGiff JC
    Br J Pharmacol; 1990 Jun; 100(2):336-40. PubMed ID: 2116203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.